Posts Tagged ‘#caribbeancovid19’

ASOFARMA CENTRAL AMERICA AND THE CARIBBEAN, THROUGH ITS HEADQUARTERS ADIUM, REACHES AN IMPORTANT AGREEMENT WITH MODERNA INC. TO COLLABORATE IN THE DISTRIBUTION AND MARKETING OF VACCINES AGAINST COVID 19 IN THE REGION

Leading company in pharmaceutical innovation, based in our country, signs unprecedented agreement for the arrival of vaccines against COVID-19

PANAMA CITY, Feb. 23, 2022 /PRNewswire-HISPANIC PR WIRE/ — ASOFARMA Central America and the Caribbean, through its parent company ADIUM, and Moderna Inc. reached a collaboration agreement for the distribution and commercialization in the region of SPIKEVAX, the vaccine developed by Moderna against SARS -CoV-2.

ASOFARMA Central America and the Caribbean is a leading pharmaceutical company in the region, which develops, produces and markets innovative products in therapeutic areas such as oncology, cardiology, central nervous system, diabetes and urology, among others.

As part of the agreement reached, ASOFARMA will collaborate with Moderna in the management of supply contracts already in force, as well as in vaccine registration processes, support for pharmacovigilance activities, continuing medical education, government affairs, marketing, and generation of new agreements that facilitate the availability of SPIKEVAX in the region.

“We are delighted to partner with Moderna to help patients, physicians and governments in this effort against COVID-19. Moderna is a leading company in the fight against the pandemic, and we are proud to have been chosen as partners for this task, providing all our experience and regional presence,” said Bernardo Girala, General Manager of ASOFARMA Central America and the Caribbean.

“This alliance confirms our purpose of providing the population with innovative treatments that help improve their quality of life and expand vaccination rates in the region,” Girala said.

Moderna Inc., a pioneer biotechnology company in the development of messenger RNA (mRNA) therapies and vaccines, has relied on ASOFARMA to make possible the arrival in the region of its vaccine against COVID 19, Spikevax.

Moderna’s mRNA platform is based on continuous advances in basic and applied mRNA science, delivery and manufacturing technology; which has allowed the development of therapies and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases.

With this new agreement reached by ASOFARMA, Moderna Inc. joins a list of international pharmaceutical and biotechnological research and development companies that ASOFARMA has represented in the region for more than twenty years.

Photo - https://mma.prnewswire.com/media/1752293/ASOFARMA.jpg

Click Here for More Information »

Ryvex and SD Biosensor donate WHO approved COVID 19 antigen kits to Barbados and the OECS

MIRAMAR, Florida, March 15, 2021 /PRNewswire-HISPANIC PR WIRE/ – Ryvex, LLC (www.ryvex.net) in partnership with SD Biosensor (www.sdbiosensor.com) have donated over 20,000 rapid Antigen tests to the OECS member states and Barbados. The kits donated have been approved by the WHO. The kits are scheduled to arrive this week to the different beneficiary island nations.

Part of the donation being loaded for shipment to Barbados and the OECS member states

In response to the COVID-19 crisis, the donation will strengthen testing response at the country level, improve services delivery capacity, support initiatives to break the chain of transmission of the illness and improve case detection and management.

Testing is the key to getting back to normal. One of Ryvex’s goals is to contribute on finding solutions to help stop the spread of COVID-19, particularly among vulnerable populations that have been disproportionately affected by this pandemic.

Barbados seemed to have avoided a destructive COVID-19 pandemic. The Caribbean nation, home to around 287 000 people, registered fewer than 400 cases of the disease for the whole of 2020. But January, 2021, saw a surge. By the end of the month, Barbados had registered well over 1000 new cases of COVID-19. On Feb 3, 2021, it went into lockdown. On the same day, Saint Lucia, an OECS member state, declared a state of emergency. It has confirmed more than three times as many cases of COVID-19 this year as it did last year. Like Barbados, Saint Lucia has imposed a nightly curfew on its 180 000 or so residents. Community transmission of COVID-19 has also been established in other parts of the Caribbean, including Haiti, Jamaica, Saint Vincent and the Grenadines, and Trinidad and Tobago.

Ryvex remains committed in aiding with the efforts to contain the COVID19 pandemic in The Caribbean region through partnerships with public and private health institutions in the region.

Ryvex is the official distributor for SD Biosensor in The Caribbean region.

Photo - https://mma.prnewswire.com/media/1456359/Ryvex_antigen_kits.jpg

Click Here for More Information »